Last10K.com

Aveo Pharmaceuticals Inc (AVEO) SEC Filing 8-K Material Event for the period ending Thursday, October 3, 2019

Aveo Pharmaceuticals Inc

CIK: 1325879 Ticker: AVEO

View differences made from one to another to evaluate Aveo Pharmaceuticals Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aveo Pharmaceuticals Inc.

Continue

Assess how Aveo Pharmaceuticals Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aveo Pharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Aveo Pharmaceuticals Inc provided additional information to their SEC Filing as exhibits

Ticker: AVEO
CIK: 1325879
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-261229
Submitted to the SEC: Thu Oct 03 2019 9:10:56 AM EST
Accepted by the SEC: Thu Oct 03 2019
Period: Thursday, October 3, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/aveo/0001193125-19-261229.htm